CYTEK BIOSCIENCES INC. news, videos and press releases
For more news please use our advanced search feature.
CYTEK BIOSCIENCES INC. - More news...
CYTEK BIOSCIENCES INC. - More news...
- Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
- Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
- Cytek Biosciences Reports First Quarter 2025 Financial Results
- Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
- Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025
- Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
- Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
- Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
- Cytek Biosciences to Participate in Upcoming Investor Conferences
- Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results
- Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference
- Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
- Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference
- Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
- Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
- Cytek Biosciences Reports Third Quarter 2024 Financial Results
- Cytek Biosciences to Participate in Upcoming Investor Conferences
- Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024
- Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
- Cytek Announces Resignation of Chief Operating Officer Chris Williams
- Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
- Cytek Biosciences to Participate in Upcoming Investor Conferences
- Cytek Biosciences Reports Second Quarter 2024 Financial Results
- Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
- Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024
- Cytek Biosciences Announces $50 Million Stock Repurchase Program
- Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
- 1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
- Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
- Cytek Biosciences Reports First Quarter 2024 Financial Results
